Byline: Melissa Rohman
-
Feinberg Celebrates 100 Years of The Journal of Clinical Investigation
Investigators from Feinberg School of Medicine and fellow academic and research institutions celebrated the 100-year anniversary of The Journal of Clinical Investigation during a day-long symposium in the Hughes Auditorium on October 18.
-
Improving the Science and Treatment of Glioblastoma
The average length of survival for glioblastoma has failed to improve since it was first identified in scientific literature nearly 100 years ago. Despite this, scientists at Feinberg remain steadfast in their commitment to improving the understanding and treatment of glioblastoma through rigorous research initiatives and clinical trials.
-
Novel Blood Test Predicts Risk of Severe Lung Disease
Northwestern Medicine investigators have created a novel blood test that identifies adults who may be at increased risk of developing severe respiratory illnesses, according to a recent study published in the American Journal of Respiratory and Critical Care Medicine.
-
Diversity and Inclusion Fall Lyceum Explores Causes of Health Inequity and Possible Solutions
Feinberg students, faculty, trainees and staff gathered in a packed Hughes Auditorium for the Office of Diversity and Inclusion’s annual Fall Lyceum on October 8.
-
Combination Therapy May Improve Treatment Response in Pancreatic Cancer
Northwestern Medicine investigators have discovered that a novel combination treatment promotes cancer cell death and tumor regression in mouse models of pancreatic cancer, providing a rationale for testing in future clinical trials, according to recent findings.
-
Targeting T-cell Lipid Metabolism May Improve Cancer Immunotherapy
Investigators have discovered that targeting specific mechanisms linked to lipid metabolism in immune cells within tumors may improve response to current and future cancer immunotherapies, according to a recent study published in the journal Immunity.
-
Northwestern Establishes New Center for Ataxia Research and Treatment
Northwestern has established the Denning Ataxia Center, a multidisciplinary hub dedicated to improving the understanding of ataxia through integrating leading-edge research with patient-centered clinical care, with the goal of unraveling the complexities of the condition and developing improved treatments.
-
Uncovering Regulatory Mechanisms of T-cells in Chronic Inflammation
Northwestern Medicine scientists have discovered a new underlying mechanism that controls a specialized group of T-cells, findings that may serve as potential targets for treating inflammatory diseases and cancer, according to a recent study.
-
Medical Students Provide Heart Disease Prevention to Underserved Chicago Communities
Since 2013, Feinberg medical students have provided cardiovascular disease risk assessments and health counseling to underserved community members across Chicago through the Keep Your Heart Healthy program.
-
Combination Treatment Extends Survival in Advanced Bladder Cancer
Immunotherapy administered before and after chemotherapy along with surgical removal of the bladder improved survival compared to chemotherapy alone in patients with muscle-invasive bladder cancer, according to a recent study published in the New England Journal of Medicine.
